DeuteRx (DRX-065 Drug) is Buildings and Property in United States that focus on clinical stage drug business. They cover business area such as development, NASH (non-alcoholic steatohepatitis, MPC) inhibitor, phase, non-alcoholic fatty liver disease.
-
Clinical Stage Drug
-
300 Brickstone Square
Suite 201
Andover, MA
United States
Private
developmentNASH (non-alcoholic steatohepatitisMPC) inhibitorphasenon-alcoholic fatty liver disease
* We use standard office opening hours in near DeuteRx (DRX-065 Drug)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
DeuteRx (DRX-065 Drug) is Buildings and Property business from United States that founded in - ( years old in ), DeuteRx (DRX-065 Drug) business is focusing on Clinical Stage Drug.
DeuteRx (DRX-065 Drug) headquarter office and corporate office address is located in 300 Brickstone Square Suite 201 Andover, MA United States.
DeuteRx (DRX-065 Drug) was founded in United States.
In , DeuteRx (DRX-065 Drug) is currently focus on clinical stage drug sector.
Above is snippet of Google Trends for "clinical stage drug" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with DeuteRx (DRX-065 Drug), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
